Cytosorbents Corp (NASDAQ:CTSO) traded at $0.94 at close of the session on Friday, January 03 and made an upward move of 1.80% on its previous day’s price.
Looking at the stock we see that its previous close was $0.92 and the beta (5Y monthly) reads 0.564 with the day’s price range being $0.8224 – $0.97. In terms of its 52-week price range, CTSO has a high of $1.59 and a low of $0.70. The company’s stock has lost about -1.41% over that past 30 days.
Cytosorbents Corp has a market cap of $52.28 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the CTSO stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is 4.17% off its SMA20 and 0.98% from its 50-day simple moving average. The RSI (14) is pointing at 52.14 while the volatility over the past week is 9.41% and jumps to 10.08% over the past one month. The beta value is 0.60, while the average true range (ATR) is currently pointing at 0.09.
Coming back to Cytosorbents Corp (NASDAQ:CTSO), we note that the average 3-month trading volume was 136.76K, while that of the preceding 10-day period stands at 0.79 million. Current shares outstanding are 54.50 million.
The insiders hold 14.51% of the company’s shares while institutions hold 31.07%. The data shows that short shares as of 2024-12-13, stood at 1.4 million at a short ratio of 10.74. This represents a 263.00 short interest in shares outstanding on 2024-12-13. Shares short rose in December from the previous month at 1.31 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 2.92% up in year-to-date price movement.
